CD47 functions by binding to its cognate receptor called Signal Regulatory Protein Alpha (SIRPα) on macrophages and dendritic cells, leading to disruption of the phagocytic synapse site, and ultimately preventing phagocytosis of the cancer cell. This evidence concerns the gene SIRPA and cancer.